phesgo

Generic: pertuzumab, trastuzumab, and hyaluronidase-zzxf

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name phesgo
Generic Name pertuzumab, trastuzumab, and hyaluronidase-zzxf
Labeler genentech, inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

hyaluronidase (human recombinant) 30000 U/15mL, pertuzumab 1200 mg/15mL, trastuzumab 600 mg/15mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-245
Product ID 50242-245_c871709f-bb8a-4e51-91ad-31c75d43548e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761170
Listing Expiration 2026-12-31
Marketing Start 2020-06-29

Pharmacologic Class

Established (EPC)
her2/neu receptor antagonist [epc] endoglycosidase [epc]
Mechanism of Action
her2/neu/cerbb2 antagonists [moa]
Chemical Structure
glycoside hydrolases [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242245
Hyphenated Format 50242-245

Supplemental Identifiers

RxCUI
2382604 2382609 2383305 2383307
UNII
P188ANX8CK K16AIQ8CTM 743QUY4VD8
NUI
N0000175661 N0000020008 N0000175531 M0009499

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phesgo (source: ndc)
Generic Name pertuzumab, trastuzumab, and hyaluronidase-zzxf (source: ndc)
Application Number BLA761170 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 30000 U/15mL
  • 1200 mg/15mL
  • 600 mg/15mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) / 15 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

50242-245-01 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE 50242-245-86 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) / 15 mL in 1 VIAL, SINGLE-DOSE

Ingredients (3)

hyaluronidase (human recombinant) (30000 U/15mL) pertuzumab (1200 mg/15mL) trastuzumab (600 mg/15mL)

Linked Drug Pages (1)

Phesgo ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "c871709f-bb8a-4e51-91ad-31c75d43548e", "openfda": {"nui": ["N0000175661", "N0000020008", "N0000175531", "M0009499"], "unii": ["P188ANX8CK", "K16AIQ8CTM", "743QUY4VD8"], "rxcui": ["2382604", "2382609", "2383305", "2383307"], "spl_set_id": ["27dd5e6b-72cd-458d-a015-cf4dab5800da"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]", "Endoglycosidase [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01)  / 15 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-245-01", "marketing_start_date": "20200629"}, {"sample": true, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86)  / 15 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-245-86", "marketing_start_date": "20210503"}], "brand_name": "Phesgo", "product_id": "50242-245_c871709f-bb8a-4e51-91ad-31c75d43548e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]", "HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "50242-245", "generic_name": "pertuzumab, trastuzumab, and hyaluronidase-zzxf", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phesgo", "active_ingredients": [{"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "30000 U/15mL"}, {"name": "PERTUZUMAB", "strength": "1200 mg/15mL"}, {"name": "TRASTUZUMAB", "strength": "600 mg/15mL"}], "application_number": "BLA761170", "marketing_category": "BLA", "marketing_start_date": "20200629", "listing_expiration_date": "20261231"}